Cargando…
Leukemia’s Next Top Model? Syngeneic Models to Advance Adoptive Cellular Therapy
In recent years, there has been an emphasis on harnessing the immune system for therapeutic interventions. Adoptive cell therapies (ACT) have emerged as an effective option for B-cell derived hematological malignancies. Despite remarkable successes with ACT, immune dysregulation and the leukemia mic...
Autores principales: | Zoine, Jaquelyn T., Moore, Sarah E., Velasquez, M. Paulina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8990900/ https://www.ncbi.nlm.nih.gov/pubmed/35401520 http://dx.doi.org/10.3389/fimmu.2022.867103 |
Ejemplares similares
-
IMMU-01. EVALUATING THE IMPACT OF CAR DESIGN ON THE TUMOR IMMUNE MICROENVIRONMENT AND ANTI-TUMOR RESPONSE IN SYNGENEIC GLIOMA MODELS
por: Haydar, Dalia, et al.
Publicado: (2023) -
Syngeneic leukemia models using lentiviral transgenics
por: Keinan, Nurit, et al.
Publicado: (2021) -
Beyond the Antigen Receptor: Editing the Genome of T-Cells for Cancer Adoptive Cellular Therapies
por: Lloyd, Angharad, et al.
Publicado: (2013) -
Potential biomarkers: Identifying powerful tumor specific T cells in adoptive cellular therapy
por: Ge, Wu, et al.
Publicado: (2022) -
Longitudinal evaluation of the biodistribution and cellular internalization of the bispecific CD3xTRP1 antibody in syngeneic mouse tumor models
por: Sandker, Gerwin Gerhard Wemke, et al.
Publicado: (2023)